产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
| 名称 | HCCLM3 （人高转移肝癌细胞）（STR鉴定正确） |
| 别称 | LM3; MHCC-LM3; MHCCLM3 |
| 种属 | 人 |
| 生长特性 | 贴壁细胞 |
| 细胞形态 | 上皮细胞样 |
| 冻存条件 | 冻存液：55% 基础培养基+40%FBS+5%DMSO 温度：液氮 |
| 培养方案A（默认） |
培养条件:
气相：空气，95%；CO2，5%, 温度：37℃
|
| 推荐传代比例 | 1:2-1:4 |
| 推荐换液频率 | 2-3天/次 |
| 背景描述 | HCCLM3细胞是一株由人肝癌细胞株MHCC97-H接种裸鼠、进行3次肺转移筛选、取肺转移瘤建成皮下接种后高度自发性肺转移的肝癌细胞系。HCCLM3细胞被广泛用于人肝癌发病机理的基础和临床研究，也可用于抗肿瘤药物筛选。 |
| 年龄（性别） | 男性；39岁 |
| 组织来源 | 肝；肝癌 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 肝胆癌细胞 |
| 生物安全等级 | BSL-1 |
| 倍增时间 | ~35-48 hours |
| 保藏机构 | CCTCC; GDC0289 |
STR鉴定
-
STR位点信息
Amelogenin X, Y CSF1PO 11,13 D2S1338 20 D3S1358 15,16 D5S818 12,13 D7S820 10 D8S1179 12,13 D13S317 8 D16S539 12 D18S51 13,22 D19S433 13,14 D21S11 31.2 FGA 21,24 PentaD 8,9 PentaE 17 TH01 9 TPOX 8 vWA 14 D6S1043 12,20 D12S391 18 D2S441 15 -
STR鉴定图
-
参考文献
-
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS–STING pathway in hepatocellular carcinoma (2024-02-05)
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2024.111628
影响因子 ：5.6
引用产品： NK-92 细胞 , HCCLM3 细胞 , 人源NK细胞完全培养基
-
USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization (2023-06-13)
期刊：Cell Death & Disease
DOI：10.1038/s41419-023-05747-7
影响因子 ：9.0
引用产品： HCCLM3 细胞 , Hep G2 细胞 , 293T [HEK-293T] 细胞
-
UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells (2023-12-12)
期刊：FREE RADICAL BIOLOGY AND MEDICINE
DOI：10.1016/j.freeradbiomed.2023.11.030
影响因子 ：7.4
引用产品： 293T [HEK-293T] 细胞 , HCCLM3 细胞 , Hep G2 细胞
-
F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner (2023-02-02)
期刊：Cancers
影响因子 ：5.2
引用产品： HCCLM3 细胞 , Hep G2 细胞 , HCC8910 细胞 , HuH-7 细胞 , HL-7702 [L-02; LO2] 细胞 , 特级胎牛血清
-
Circ_0007429/miR-637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC (2023-03-15)
期刊：MOLECULAR CARCINOGENESIS
DOI：10.1002/mc.23526
影响因子 ：4.6
引用产品： HuH-7 细胞 , Hep G2 细胞 , HCCLM3 细胞 , SK-Hep-1 细胞 , Hep 3B2.1-7 细胞 , MHCC97-L 细胞
-
Comprehensive Analysis of NABP2 as a Prognostic Biomarker and Its Correlation with Immune Infiltration in Hepatocellular Carcinoma (2023-04-20)
期刊：Journal of Inflammation Research
影响因子 ：4.5
引用产品： HCCLM3 细胞
-
Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217/high mobility group AT-hook 2 (HMGA2) axis. (2023-06-09)
期刊：Heliyon
DOI：10.1016/j.heliyon.2023.e17120
影响因子 ：4.0
引用产品： HL-7702 [L-02; LO2] 细胞 , HuH-7 细胞 , HCCLM3 细胞 , Hep 3B2.1-7 细胞
-
BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1 (2023-06-29)
期刊：CANCER BIOLOGY & THERAPY
DOI：10.1080/15384047.2023.2225884
影响因子 ：3.6
引用产品： HuH-7 细胞 , HCCLM3 细胞 , DMEM高糖 培养基
-
The long noncoding RNA TINCR promotes self-renewal of human liver cancer stem cells through autophagy activation (2022-11-16)
期刊：Cell Death & Disease
DOI：10.1038/s41419-022-05424-1
影响因子 ：9.7
引用产品： HCCLM3 细胞 , MHCC97-L 细胞
-
Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles (2022-12-26)
期刊：OncoImmunology
DOI：10.1080/2162402X.2022.2152635
影响因子 ：7.7
引用产品： HuH-7 细胞 , HCCLM3 细胞 , MHCC97-L 细胞 , RPMI-1640 培养基 , BNL 1ME A.7R.1 细胞 , DMEM高糖 培养基 , 小鼠骨髓间充质干细胞 , Hank's平衡盐溶液 (HBSS)，含钙、镁，不含酚红
-
LncRNA SNHG6 promotes glycolysis reprogramming in hepatocellular carcinoma by stabilizing the BOP1 protein (2022-12-06)
期刊：Animal Cells and Systems
DOI：10.1080/19768354.2022.2134206
影响因子 ：2.4
引用产品： HL-7702 [L-02; LO2] 细胞 , Hep G2 细胞 , SMMC-7721 细胞 , HCCLM3 细胞
-
lncRNA PRR34-AS1 promotes HCC development via modulating Wnt/β-catenin pathway by absorbing miR-296-5p and upregulating E2F2 and SOX12 (2004-01-20)
期刊：Molecular Therapy-Nucleic Acids
DOI：10.1016/j.omtn.2021.04.016
影响因子 ：8.8
引用产品： HCCLM3 细胞
-
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway (2011-01-20)
期刊：Cellular & Molecular Biology Letters
DOI：10.1186/s11658-021-00295-4
影响因子 ：8.3
引用产品： HCCLM3 细胞 , HuH-7 细胞 , Hep 3B2.1-7 细胞 , SK-Hep-1 细胞
-
CircWHSC1 serves as an oncogene to promote hepatocellular carcinoma progression (2004-01-20)
期刊：European Journal Of Clinical Investigation
影响因子 ：5.5
引用产品： HCCLM3 细胞
-
CCAT2 enhances autophagy-related invasion and metastasis via regulating miR-4496 and ELAVL1 in hepatocellular carcinoma (2008-01-20)
期刊：Journal Of Cellular And Molecular Medicine
影响因子 ：5.3
-
ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway (2006-01-20)
期刊：Cell Cycle
DOI：10.1080/15384101.2021.1919828
影响因子 ：4.3
引用产品： HCCLM3 细胞 , Hep 3B2.1-7 细胞 , HuH-7 细胞
-
Ultrasound-Targeted Microbubble Destruction-Mediated Downregulation of EZH2 Inhibits Stemness and Epithelial-Mesenchymal Transition of Liver Cancer Stem Cells (2001-01-20)
期刊：OncoTargets and Therapy
影响因子 ：4.3
-
AC093797.1 as a Potential Biomarker to Indicate the Prognosis of Hepatocellular Carcinoma and Inhibits Cell Proliferation, Invasion, and Migration by Reprogramming Cell Metabolism and Extracellular Matrix Dynamics (2012-01-20)
期刊：Frontiers in Genetics
影响因子 ：3.7
-
circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma (2004-01-20)
期刊：Molecular Medicine Reports
影响因子 ：3.4
引用产品： HCCLM3 细胞
-
HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p (2003-00-20)
期刊：Cell Death & Disease
影响因子 ：9.0
引用产品： HCCLM3 细胞
-
LncRNA RHPN1-AS1 accelerates proliferation, migration, and invasion via regulating miR-485-5p/BSG axis in hepatocellular carcinoma (2005-00-20)
期刊：Naunyn-Schmiedebergs Archives of Pharmacology
DOI：10.1007/s00210-020-01889-z
影响因子 ：3.6
引用产品： HCCLM3 细胞 , SMMC-7721 细胞
-
CXCL14 inhibits the growth and promotes apoptosis of hepatocellular carcinoma cells via suppressing Akt/mTOR pathway (2010-00-20)
期刊：Journal Of Receptors And Signal Transduction
DOI：10.1080/10799893.2020.1837870
影响因子 ：2.8
-
Curcumin Inhibits Hepatocellular Carcinoma via Regulating miR-21/TIMP3 Axis (2007-00-20)
期刊：Evidence-Based Complementary and Alternative Medicine
影响因子 ：2.7
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
